Follow
"One of the next horizons is to figure out how to engineer the (CART) cells inside a patient’s body, known as in vivo—a much more direct and efficient approach. Weissman is working on targeted T-cell delivery of RNA therapies."
"One of the next horizons is to figure out how to engineer the (CART) cells inside a patient’s body, known as in vivo—a much more direct and efficient approach. Weissman is working on targeted T-cell delivery of RNA therapies."